Quest Diagnostics (DGX) Long-Term Debt Issuances (2009 - 2026)
Quest Diagnostics (DGX) posted Long-Term Debt Issuances of $500.0 million for Q2 2026, up 49900.0% sequentially from $1.0 million in Q1 2026, and up 24.69% YoY from $401.0 million in Q2 2025.
Quest Diagnostics (DGX) Long-Term Debt Issuances (2009 - 2026) Analysis & Trends
Quest Diagnostics has reported Long-Term Debt Issuances for 18 years, with the latest figure at $500.0 million in Q2 2026.
- Quarterly Long-Term Debt Issuances rose 24.69% year-over-year to $500.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $512.0 million (down 79.89% YoY) and the FY2025 annual result came in at $1.0 billion, down 45.18% from the prior year.
- Long-Term Debt Issuances improved to $500.0 million in Q2 2026 per DGX's latest filing, from $1.0 million in the prior quarter.
- Over five years, Long-Term Debt Issuances peaked at $1.5 billion in Q3 2024 and troughed at $1.0 million in Q1 2022.
- A 5-year average of $425.2 million and a median of $351.0 million in 2024 frame the typical range for Long-Term Debt Issuances.
- The sharpest annual moves came in 2023 and 2026: Long-Term Debt Issuances soared 88800.0% in 2023, then plunged 99.83% in 2026.
- Over 5 years, Long-Term Debt Issuances stood at $1.0 million in 2022, then jumped by 88800.0% to $889.0 million in 2023, then surged by 73.79% to $1.5 billion in 2024, then slumped by 99.94% to $1.0 million in 2025, then surged by 49900.0% to $500.0 million in 2026.
- According to Business Quant data, Long-Term Debt Issuances over the past three periods registered $500.0 million, $1.0 million, and $1.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | LT Debt Issuance (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | - |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 6.56 Bn |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | - |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | - |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 1.11 Bn |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | - |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | - |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 442.41 Mn |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 500.00 Mn |
| 10 | Labcorp Holdings | 25.87 Bn | 24.89 Bn | 1.01 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 500.00 Mn |
| Jun 30, 2026 | 500.00 Mn |
| Mar 31, 2026 | 1.00 Mn |
| Mar 31, 2026 | 1.00 Mn |
| Dec 31, 2025 | 1.00 Mn |
| Dec 31, 2025 | 1.00 Mn |
| Sep 30, 2025 | 10.00 Mn |
| Sep 30, 2025 | 10.00 Mn |
| Jun 30, 2025 | 401.00 Mn |
| Jun 30, 2025 | 401.00 Mn |
| Mar 31, 2025 | 600.00 Mn |
| Mar 31, 2025 | 600.00 Mn |
| Sep 30, 2024 | 1.55 Bn |
| Sep 30, 2024 | 1.55 Bn |
| Jun 30, 2024 | 301.00 Mn |
| Jun 30, 2024 | 301.00 Mn |
| Dec 31, 2023 | 889.00 Mn |
| Dec 31, 2023 | 889.00 Mn |
| Sep 30, 2023 | 556.00 Mn |
| Sep 30, 2023 | 556.00 Mn |